These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 33611315)
1. Subcutaneous Allergen-Specific Immunotherapy Is Safe in Pediatric Patients with Allergic Rhinitis. Pavon-Romero GF; Larenas-Linnemann DE; Xochipa Ruiz KE; Ramirez-Jimenez F; Teran LM Int Arch Allergy Immunol; 2021; 182(6):553-561. PubMed ID: 33611315 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness and adverse reactions to subcutaneous immunotherapy in children with allergic rhinitis/asthma. Duman Senol H; Topyildiz E; Ekici B; Gulen F; Demir E Int J Pediatr Otorhinolaryngol; 2022 Nov; 162():111292. PubMed ID: 36007303 [TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of immunotherapy in allergic rhinitis. Oktemer T; Altıntoprak N; Muluk NB; Senturk M; Kar M; Bafaqeeh SA; Bellussi L; Passali D; Cingi C Am J Rhinol Allergy; 2016 Sep; 30(5):4-7. PubMed ID: 29025463 [TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of immunotherapy in allergic rhinitis. Oktemer T; Altıntoprak N; Muluk NB; Senturk M; Kar M; Bafaqeeh SA; Bellussi L; Passali D; Cingi C Am J Rhinol Allergy; 2016 Sep; 30(5):4-7. PubMed ID: 27658025 [TBL] [Abstract][Full Text] [Related]
5. Indonesia-Based Study of the Clinical and Cost-Saving Benefits of Subcutaneous Allergen Immunotherapy for Children with Allergic Rhinitis in Private Practice. Endaryanto A; Nugraha RA Cells; 2021 Jul; 10(7):. PubMed ID: 34360010 [TBL] [Abstract][Full Text] [Related]
6. Does evidence support the use of cat allergen immunotherapy? Dhami S; Agarwal A Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):350-355. PubMed ID: 29870462 [TBL] [Abstract][Full Text] [Related]
7. Clinical Response to Subcutaneous Dermatophagoides pteronyssinus Immunotherapy in Children with Allergic Rhinitis and Asthma Is Independent of Sensitization to Blomia tropicalis Allergens. Chen S; Zheng Y; Chen B; Zhong H; Liao F; Wang L; Hui SF; Lai X Int Arch Allergy Immunol; 2019; 178(2):201-210. PubMed ID: 30544116 [TBL] [Abstract][Full Text] [Related]
8. Risk of systemic allergic reactions to allergen immunotherapy in a pediatric allergy clinic in Turkey. Bahceci Erdem S; Nacaroglu HT; Karaman S; Unsal Karkıner CS; Gunay I; Dogan D; Asilsoy S; Altınoz S; Can D Int J Pediatr Otorhinolaryngol; 2016 May; 84():55-60. PubMed ID: 27063754 [TBL] [Abstract][Full Text] [Related]
9. [Observation and analysis of systemic reactions to house dust mite subcutaneous immunotherapy in 362 patients with allergic rhinitis]. Xue JR; Ma J; Qiu CY; Hu ZB; Jiang X; Pan M; Lu MP; Cheng L Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 May; 55(5):445-451. PubMed ID: 32842357 [No Abstract] [Full Text] [Related]
10. Sublingual or subcutaneous immunotherapy for allergic rhinitis? Durham SR; Penagos M J Allergy Clin Immunol; 2016 Feb; 137(2):339-349.e10. PubMed ID: 26853126 [TBL] [Abstract][Full Text] [Related]
11. [An analysis of the subcutaneous immunotherapy on the pulmonary function and symptoms of asthma and rhinitis in children]. Wu SJ; Chen S; Chen B; Wang L; Zeng X Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Sep; 31(17):1352-1355. PubMed ID: 29798230 [No Abstract] [Full Text] [Related]
12. The efficacy assessment of a self-administered immunotherapy protocol. Schaffer FM; Garner LM; Ebeling M; Adelglass JM; Hulsey TC; Naples AR Int Forum Allergy Rhinol; 2016 Feb; 6(2):148-55. PubMed ID: 26467843 [TBL] [Abstract][Full Text] [Related]
13. Characterisation of systemic reactions to subcutaneous immunotherapy with airborne allergens and classification according to WAO 2010. Santos N; Pereira AM; Silva R; Torres da Costa J; Plácido JL Allergol Immunopathol (Madr); 2015; 43(1):25-31. PubMed ID: 24661594 [TBL] [Abstract][Full Text] [Related]
14. House Dust Mite Sublingual Immunotherapy for Pediatric Patients With Allergic Asthma. Richards JR; Stumpf JL Ann Pharmacother; 2018 Oct; 52(10):1019-1030. PubMed ID: 29642713 [TBL] [Abstract][Full Text] [Related]
15. Specific immunotherapy in local allergic rhinitis: A randomized, double-blind placebo-controlled trial with Phleum pratense subcutaneous allergen immunotherapy. Rondón C; Blanca-López N; Campo P; Mayorga C; Jurado-Escobar R; Torres MJ; Canto G; Blanca M Allergy; 2018 Apr; 73(4):905-915. PubMed ID: 29168570 [TBL] [Abstract][Full Text] [Related]
16. Safety and Effectiveness of a Single Multiallergen Subcutaneous Immunotherapy in Polyallergic Patients. Nevot-Falcó S; Mancebo EG; Martorell A; Calatayud CM; Perotti SC; Rojas MJ; Rodriguez-Rodriguez M; Padial MA; El Qutob Lopez FD; Perez-Camo I; Gomez-Brenosa B; Cano MDMG; Gonzalez de Olano D; Ferre-Ybarz L; López FF; Lara Jiménez Á; Aldunate-Muruzabal T; Pascual MC; Villas F; Garcia EC; Reche M; Antolin-Amerigo D; Barbarroja-Escudero J; Romero EN; Ruiz-Garcia M Int Arch Allergy Immunol; 2021; 182(12):1226-1230. PubMed ID: 34392241 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of subcutaneous immunotherapy for allergic rhinoconjunctivitis and asthma: a systematic review. Erekosima N; Suarez-Cuervo C; Ramanathan M; Kim JM; Chelladurai Y; Segal JB; Lin SY Laryngoscope; 2014 Mar; 124(3):616-27. PubMed ID: 23832632 [TBL] [Abstract][Full Text] [Related]
18. Benefit of SLIT and SCIT for Allergic Rhinitis and Asthma. Passalacqua G; Canonica GW; Bagnasco D Curr Allergy Asthma Rep; 2016 Nov; 16(12):88. PubMed ID: 27957697 [TBL] [Abstract][Full Text] [Related]
19. [Comparison study of subcutaneous immunotherapy and sublingual immunotherapy in patients with allergic rhinitis]. You SH; Qin XY; Xu C; Qiu X; Luan ZL; Jia HX; Wang HT Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 30(9):689-693. PubMed ID: 29771014 [No Abstract] [Full Text] [Related]
20. Safety of subcutaneous immunotherapy with inhalant allergen extracts: a single-center 30-year experience from Turkey. Kartal O; Gulec M; Caliskaner Z; Musabak U; Sener O Immunopharmacol Immunotoxicol; 2015 Jun; 37(3):280-6. PubMed ID: 25858053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]